The Board of Directors of Rubfila International Limited, at its meeting held on August 20, 2026, considered and approved the divestment of the company’s entire shareholding in its wholly owned subsidiary, Premier Tissues (India) Limited (PTIL), to M/s. Finquest Personal Care Pvt. Ltd. for an aggregate cash consideration of ₹61.00 crore. This strategic decision aims to allow the company to preserve and deploy its financial resources more effectively toward its core rubber-thread business. The transaction is structured on an “as is where is” basis, requiring no further due diligence, and is subject to necessary shareholder and statutory approvals. During the previous financial year ended March 31, 2026, PTIL contributed a turnover of ₹95.74 crore (representing 15.68% of the company’s consolidated revenue) and a net worth of ₹51.49 crore. The proposed purchaser is associated with Mr. Hardik Patel, Chairman and member of the promoter group, who properly recused himself from the board deliberations. The transaction documents are anticipated to be executed on or before September 10, 2026, with the final payment slated within 30 days of receiving the requisite approvals.

Rubfila International Limited is a prominent manufacturer specializing in heat-resistant rubber thread and related rubber-based products, catering to diverse domestic and industrial applications. Headquartered in Palakkad, Kerala, the company has built a strong reputation for maintaining high manufacturing standards and expanding its market footprint across various sectors. Recent corporate actions emphasize optimizing operational focus by shedding non-core segments to reinforce balance sheet strength and drive core competencies. Industry updates highlight steady domestic demand and stable export performance, aiding the company’s continuous manufacturing enhancements and long-term positioning within the niche rubber-thread industry.

During the financial year 2025, Rubfila International demonstrated positive operational performance, highlighted by solid revenue expansion across its core product segments driven by healthy domestic demand and stable pricing structures. The company’s focus on efficient inventory management and working capital controls supported overall business stability. While specific institutional holdings and individual famous investors vary based on quarterly shareholding patterns, the company continues to attract steady market interest due to its debt-light balance sheet and resilient operational model.